Galera Therapeutics, Inc. — SC 13G/A Filings
18 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Galera Therapeutics, Inc. (GRTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Galera Therapeutics, Inc. has filed 18 SC 13G/A documents with the SEC since 2012. To view all SEC filings by Galera Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
25-NSE
3
4
4/A
424B4
424B5
425
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-Q
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | AMENDMENT NO. 2 TO FORM SC 13G | 0001213900-24-044071 | May 16, 2024 | — |
| SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-24-038572 | May 1, 2024 | — |
| SC 13G/A | AMENDMENT NO. 1 TO FORM SC 13G | 0001683168-24-002071 | Apr 3, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-023133 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-23-177520 | Jun 28, 2023 | — |
| SC 13G/A | GALERA THERAPEUTICS, INC. | 0001104659-22-021334 | Feb 14, 2022 | — |
| SC 13G/A | SC 13G/A | 0001104659-22-020559 | Feb 11, 2022 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-035528 | Feb 11, 2022 | — |
| SC 13G/A | GALERA THERAPEUTICS, INC. | 0000902664-22-001324 | Feb 10, 2022 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-025833 | Feb 2, 2022 | — |
| SC 13G/A | — | 0001493152-21-025870 | Oct 20, 2021 | — |
| SC 13G/A | AMENDED SCHEDULE 13G | 0001387131-21-006370 | Jun 7, 2021 | — |
| SC 13G/A | SC 13G/A | 0001193125-21-045144 | Feb 16, 2021 | — |
| SC 13G/A | SC 13G/A | 0001104659-21-023936 | Feb 16, 2021 | — |
| SC 13G/A | GALERA THERAPEUTICS, INC. | 0000902664-21-001124 | Feb 11, 2021 | — |
| SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0001193125-21-032451 | Feb 8, 2021 | — |
| SC 13G/A | SC 13G/A | 0001104659-21-010160 | Feb 1, 2021 | — |
| SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001193125-20-025138 | Feb 5, 2020 | — |